{"id":169131,"date":"2025-07-14T09:02:39","date_gmt":"2025-07-14T13:02:39","guid":{"rendered":"https:\/\/44.250.171.167\/?p=169131"},"modified":"2025-07-14T09:02:39","modified_gmt":"2025-07-14T13:02:39","slug":"suven-life-sciences-ltd-q4fy25-50-fall-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/suven-life-sciences-ltd-q4fy25-50-fall-in-revenue\/","title":{"rendered":"Suven Life Sciences Ltd Q4FY25; 50% fall in Revenue"},"content":{"rendered":"<p>Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders.<\/p>\n<h2>\nFinancial Results:<\/h2>\n<p>Suven Life Sciences Ltd reported Revenues for Q4FY25 of \u20b91.00 Crores down from \u20b92.00 Crore year on year, a fall of 50.0%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b946.00 Crores up from \u20b935.00 Crores year on year, a rise of 31.43%.<\/p>\n<p>Consolidated Net Profit of -\u20b944.00 Crores from -\u20b927.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is -\u20b92.01, from -\u20b91.22 in the same quarter of the previous year.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-169132\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6-839x1024.png\" alt=\"\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q4FY25 of \u20b91.00 Crores down from \u20b92.00 Crore year on year, a fall of 50.0%. Total Expenses for Q4FY25 of \u20b946.00 [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":169132,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[11776,3059,11978],"class_list":["post-169131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-active-pharmaceutical-ingredients","tag-biopharma","tag-medicines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/2-6.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":170125,"url":"https:\/\/alphastreet.com\/india\/suven-life-sciences-q1-fy26-earnings-results\/","url_meta":{"origin":169131,"position":0},"title":"Suven Life Sciences Q1 FY26 Earnings Results","author":"Chirag Gupta","date":"August 13, 2025","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. The company has been working towards developing new molecules\/ compounds in the complex CNS (central nervous system) space. Most of its lead molecules address the\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Suven Life Sciences Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151736,"url":"https:\/\/alphastreet.com\/india\/suven-life-sciences-ltd-q1fy24-0-equalled-in-revenue\/","url_meta":{"origin":169131,"position":1},"title":"Suven Life Sciences Ltd Q1FY24; 0% equalled in Revenue","author":"Chirag Gupta","date":"August 8, 2023","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q1FY24 of \u20b94.00 Crores same from \u20b94.00 Crore year on year. Total Expenses for Q1FY24 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-355.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157352,"url":"https:\/\/alphastreet.com\/india\/life-sciences-ltd-q2fy24-25-fall-in-revenue\/","url_meta":{"origin":169131,"position":2},"title":"Life Sciences Ltd Q2FY24; 25% fall in Revenue","author":"Chirag Gupta","date":"December 14, 2023","format":false,"excerpt":"Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment of neurodegenerative disorders. Financial Results: Suven Life Sciences Ltd reported Revenues for Q2FY24 of \u20b93.00 Crores down from \u20b94.00 Crore year on year, a fall of 25.0%. Total\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-111.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156068,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q2fy24-11-rise-in-profits\/","url_meta":{"origin":169131,"position":3},"title":"Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits","author":"Chirag Gupta","date":"November 10, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q2FY24 of \u20b9231.00 Crores down from \u20b9278.00 Crore year on year, a fall of 16.91%. Total Expenses for Q2FY24 of \u20b9145.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-141.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151914,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q1fy24-12-rise-in-profits\/","url_meta":{"origin":169131,"position":4},"title":"Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits","author":"Chirag Gupta","date":"August 9, 2023","format":false,"excerpt":"Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial Results: Suven Pharmaceuticals Ltd reported Revenues for Q1FY24 of \u20b9348.00 Crores up from \u20b9339.00 Crore year on year, a rise of 2.65%. Total Expenses for Q1FY24 of \u20b9195.00\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-415.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162853,"url":"https:\/\/alphastreet.com\/india\/suven-pharmaceuticals-ltd-q4fy24-57-fall-in-profits\/","url_meta":{"origin":169131,"position":5},"title":"Suven Pharmaceuticals Ltd Q4FY24; 57% fall in Profits","author":"Chirag Gupta","date":"July 9, 2024","format":false,"excerpt":"Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations. Financial Results: Suven Pharmaceuticals Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-68.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=169131"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/169131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/169132"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=169131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=169131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=169131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}